Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen

Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo Gordon, Jane Winter, Shuo Ma, Valerie Nelson, Timothy S. Fenske, Nirav N. Shah, Deepa Jagadeesh, Andreas Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M. Evens, Barbara Pro

Blood Adv (2024) 8 (7): 1612–1620.

https://doi.org/10.1182/bloodadvances.2023011369

Published: 2024

Includes: Supplemental data